Vitamin Supplement Use Among Children With Down's Syndrome and Risk of Leukaemia: A Children's Oncology Group (COG) Study

Paediatric and Perinatal Epidemiology - United Kingdom
doi 10.1111/j.1365-3016.2008.00928.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Maternal Vitamin and Iron Supplementation and Risk of Infant Leukaemia: A Report From the Children's Oncology Group

British Journal of Cancer
Cancer ResearchOncology
2010English

Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Standard of Care for Neuropsychological Monitoring in Pediatric Neuro-Oncology: Lessons From the Children's Oncology Group (COG)

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2015English

Young Children With Down's Syndrome

BMJ
1975English

Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Refractive Development in Children With Down's Syndrome: A Population Based, Longitudinal Study

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2001English

Estimating Risk of Down's Syndrome.

BMJ
1991English

Spermicide Use and Down's Syndrome.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1982English

Rasburicase in the Prevention of Laboratory/Clinical Tumour Lysis Syndrome in Children With Advanced Mature B-Nhl: A Children's Oncology Group Report

British Journal of Haematology
Hematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy